Olaplex director cashed out in $2.06 merger
OLAPLEX HOLDINGS, INC. director Christine Dagousset reported disposing of her entire equity position in connection with the company’s merger.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
OLAPLEX HOLDINGS, INC. director Christine Dagousset reported disposing of her entire equity position in connection with the company’s merger. Each common share was converted into the right to receive $2.06 in cash at the merger’s effective time.
Dagousset’s Form 4 shows 254,483 shares of common stock disposed of to the issuer and all 506,250 company stock options cancelled and converted into cash. The options had a per-share exercise price of $0.76, so each was converted into $1.30 in cash, the excess of the merger price over the strike. Footnotes also note 110,294 shares underlying RSU awards were cancelled for cash, leaving her with zero reported shares and options afterward.
Insider Trade Summary
Disposition: 760,733 shares
Disposition
2 txns
Insider
Dagousset Christine
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Company Stock Options | 506,250 | $0.00 | $0.00 |
| Disposition | Common Stock | 254,483 | $2.06 | $524K |
Holdings After Transaction:
Company Stock Options — 0 contracts (Direct);
Common Stock — 0 shares (Direct)
Footnotes (4)
- F1. Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation ("Parent"), and Margot Acquisition Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger" and, together with the other transactions contemplated by the Merger Agreement, the "Transactions"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock of the Issuer (each, a "Share") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration"), without interest, subject to any withholding of taxes required by applicable law.
- F2. At the Effective Time, each award of restricted stock units covering Shares granted under the Issuer's 2021 Equity Incentive Plan, the Issuer's Amended & Restated 2020 Omnibus Equity Incentive Plan, or any other effective equity or equity-based incentive plan sponsored by the Issuer or its affiliates (collectively, the "Company Equity Plans") (each such award, a "Company RSU Award") that was outstanding immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company RSU Award, multiplied by (y) the Merger Consideration. The amount reported includes 110,294 Shares underlying the Reporting Person's Company RSU Awards, which were automatically cancelled and converted into the right to receive the Merger Consideration at the Effective Time.
- F3. At the Effective Time, each option to purchase Shares granted under the Issuer's Company Equity Plans (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company Option, multiplied by (y) the excess, if any, of the Merger Consideration over the per Share exercise price of such Company Option; provided, however, that any Company Option that had a per Share exercise price that was equal to or greater than the Merger Consideration was cancelled for no consideration. The Reporting Person's Company Options had a per Share exercise price of $0.76, which was less than the Merger Consideration of $2.06 per Share.
- F4. (Continued from footnote 3) Accordingly, all 506,250 of the Reporting Person's Company Options were cancelled and converted into the right to receive $1.30 per Share in cash (being the excess of the Merger Consideration of $2.06 over the per Share exercise price of $0.76) at the Effective Time.
Key Figures
Common shares disposed: 254,483 shares
Merger cash price: $2.06 per share
Options cancelled: 506,250 options
+4 more
7 metrics
Common shares disposed
254,483 shares
Disposition to issuer at merger effective time
Merger cash price
$2.06 per share
Cash consideration per Olaplex common share in merger
Options cancelled
506,250 options
Company stock options disposed in issuer transaction
Option exercise price
$0.76 per share
Per-share strike price of cancelled options
Option cash payout per share
$1.30 per share
Merger consideration minus option exercise price
RSU underlying shares
110,294 shares
Shares underlying RSU awards cancelled for cash
Shares after transaction
0 shares
Total reported common shares following disposition
Key Terms
Agreement and Plan of Merger, Merger Consideration, Company RSU Award, Company Equity Plans, +2 more
6 terms
Agreement and Plan of Merger regulatory
"Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026..."
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
Merger Consideration financial
"was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration")..."
Merger consideration is the total payment a company or buyer offers to shareholders of a target company in exchange for combining the two businesses, and can include cash, shares in the surviving company, debt assumption, or a mix of these. Investors care because the form and amount affect the deal’s value, tax consequences, immediate cash received versus future ownership, and the risk and upside of holding new shares — similar to choosing between cash now or stock that could grow later.
Company RSU Award financial
"each such award, a "Company RSU Award") that was outstanding immediately prior to the Effective Time..."
Company Equity Plans financial
"under the Issuer's 2021 Equity Incentive Plan, the Issuer's Amended & Restated 2020 Omnibus Equity Incentive Plan... (collectively, the "Company Equity Plans")"
Company Option financial
"each option to purchase Shares granted under the Issuer's Company Equity Plans (each, a "Company Option")..."
Effective Time regulatory
"At the effective time of the Merger (the "Effective Time"), each share of Common Stock..."
The exact clock time when a regulatory filing, approval, or corporate action formally becomes legally active; from that moment the change is binding and can be acted on. Investors care because the effective time marks when ownership, rights, trading rules, or new securities take effect — like a light switch turning on a contract or transaction — which determines when risks, benefits and market reactions begin.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Olaplex (OLPX) director Christine Dagousset report on this Form 4?
Christine Dagousset reported disposing of her entire Olaplex equity position. Her common shares, stock options, and RSU-based shares were all cancelled or converted into cash as part of a merger transaction at a fixed cash price per share.
How were Christine Dagousset’s Olaplex stock options treated in the merger?
Her 506,250 Olaplex stock options, each with a $0.76 exercise price, were cancelled and converted into cash. For each underlying share, she became entitled to $1.30, which equals the merger consideration of $2.06 minus the per-share option exercise price.
What happened to Christine Dagousset’s Olaplex RSU awards?
All outstanding RSU awards covering Olaplex shares were automatically cancelled at the merger effective time. For Dagousset, this included 110,294 underlying shares, which were converted into the right to receive cash based on multiplying those shares by the $2.06 merger consideration.
AI-generated analysis. How Rhea-AI works. Not financial advice.
